Unrelated bone-marrow transplantation in adults

Blood Reviews

Volumn 10, Issue 4, 1996, Pages 220-230

  Huntly, B J P ^a   Franklin, I M ^b,c   Pippard, M J ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

^c GLASGOW ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; ANTINEOPLASTIC AGENT; CYCLOSPORIN; LYMPHOCYTE ANTIBODY; METHOTREXATE; PREDNISOLONE; TACROLIMUS;

ACUTE LEUKEMIA; ALLOGENIC BONE MARROW TRANSPLANTATION; APLASTIC ANEMIA; AUTOLOGOUS BONE MARROW TRANSPLANTATION; BONE MARROW TRANSPLANTATION; CANCER CHEMOTHERAPY; CANCER IMMUNOTHERAPY; CHRONIC MYELOID LEUKEMIA; CONFERENCE PAPER; DONOR; GRAFT VERSUS HOST REACTION; HEMATOLOGIC DISEASE; HLA MATCHING; HUMAN; LEUKEMIA; LYMPHOMA; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0030466791     PISSN: 0268960X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0268-960X(96)90005-3     Document Type: Conference Paper

References (85)

1. Armitage JO. Bone marrow transplantation. N Engl J Med 1994; 330: 827-838.
2. Ash RC, Casper JT, Chitambar CR et al. Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med 1990; 322: 485-494.
3. Anasetti C, Amos D, Beatty PG et al. Effect of HLA compatibility on engraftment of bone marrow transplants in patients with leukemia or lymphoma. N Engl J Med 1989; 320: 197-204.
4. Ash RC, Horowitz MM, Gale RP et al. Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T-cell depletion. Bone Marrow Transplant 1991; 7: 443-452.
5. Beatty PG, Clift RA, Mickelson EM et al. Marrow transplantation from related donors other than HLA-identical siblings. N Engl J Med 1985; 313: 765-771.
6. Speck B, Zwaan FE, Rood JJ, Eernisse JG. Allogeneic bone marrow transplantation in a patient with aplastic anemia using a phenotypically HL-A-identical unrelated donor. Transplantation 1973; 16: 24-28.
7. Hansen JA, Clift RA, Thomas ED, Buckner CD, Storb R, Giblett ER. Transplantation of marrow from an unrelated donor to a patient with acute leukemia. N Engl J Med 1980; 303: 565-567.
8. Atkinson IC. Unrelated donor bone marrow transplantation. In: Atkinson IC, ed. Clinical Bone Marrow Transplantation. A Reference Textbook. Cambridge: Cambridge University Press, 1994; 277-283.
9. Beatty PG, Dahlberg S, Miccelson EM et al. Probability of finding HLA-matched unrelated marrow donors. Transplantation 1988; 45: 714-718.
10. Petersdorf EW, Longton G, Anasetti C, Martin PJ, Hansen JA. HLA matching in unrelated donor marrow transplants. Exp Haematol 1995; 742(Abstract).
11. Howard MR, Hows JM, Gore SM et al. Unrelated donor marrow transplantation between 1977 and 1987 at four centers in the United Kingdom. Transplantation 1990; 49: 547-553.
12. Kernan NA, Bartsch G, Ash RC et al. Analysis of 462 transplantations from unrelated donors facilitated by the National Marrow Donor Program. N Engl J Med 1993; 328: 593-602.
13. McGlave P, Bartsch G, Anasetti C et al. Unrelated donor marrow transplantation therapy for chronic myelogenous leukemia: initial experience of the National Marrow Donor Program. Blood 1993; 81: 543-550.
14. McGlave PB, Beatty P, Ash R, Hows JM. Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases [published erratum appears in Blood 1990; 76:654]. Blood 1990; 75: 1728-1732.
15. Marks DI, Cullis JO, Ward KN et al. Allogeneic bone marrow transplantation for chronic myeloid leukemia using sibling and volunteer unrelated donors. A comparison of complications in the first 2 years. Ann Intern Med 1993; 119: 207-214.
16. Gajewski JL, Ho WG, Feig SA et al. Bone marrow transplantation using unrelated donors for patients with advanced leukemia or bone marrow failure. Transplantation 1990; 50: 244-249.
17. Beatty PG, Anasetti C, Hansen JA et al. Marrow transplantation from unrelated donors for treatment of hematological malignancies: effect of mismatching for one HLA locus. Blood 1993; 81: 249-253.
18. Kaminski E, Hows JM, Man S et al. Prediction of graft versus host disease by frequency analysis of cytotoxic cells after unrelated donor transplantation. Transplantation 1989; 48: 609-613.
19. Spencer A, Kaminski E, Hows J M. CTLp frequency predicts outcome in volunteer unrelated BMT for chronic phase CML. Exp Hematol 1994; 22: 715.
20. Fussell ST, Donnellan M, Cooley MA, Farrell C. Cytotoxic T lymphocyte precursor frequency does not correlate with either the incidence or severity of graft-versus-host disease after matched unrelated donor bone marrow transplantation. Transplantation 1994; 57: 673-676.
21. Storb R, Deeg HJ, Whitehead J et al. Methotrexate and cyclosporine compared with cyclosporine alone for prophylaxis of acute graft versus host disease after marrow transplantation for leukemia. N Engl J Med 1986; 314: 729-735.
22. Leelasiri A, Greer JP, Stein RS et al. Graft-versus-host-disease prophylaxis for matched unrelated donor bone marrow transplantation: comparison between cyclosporine-methotrexate and cyclosporine-methotrexate-methylprednisolone. Bone Marrow Transplant 1995; 15: 401-405.
23. Phillips GL, Nevill TJ, Spinelli JJ et al. Prophylaxis for acute graft-versus-host disease following unrelated donor bone marrow transplantation. Bone Marrow Transplant 1995; 15: 213-219.
24. Weisdorf D, Filipovich A, McGlave P et al. Combination graft-versus-host disease prophylaxis using immunotoxin (anti-CD5-RTA [Xomazyme-CD5]) plus methotrexate and cyclosporine or prednisone after unrelated donor marrow transplantation. Bone Marrow Transplant 1993; 12: 531-536.
25. Fay JW, Nash RA, Wingard JR et al. FK 506-based immunosuppression for prevention of graft versus host disease after unrelated donor marrow transplantation. Transplant Proc 1995; 27: 1374.
26. Goldman JM, Gale RP, Horowitz MM et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806-814.
27. Marmont AM, Horowitz MM, Gale RP et al. T-cell depletion of HLA-identical transplants in leukemia. Blood 1991; 78: 2120-2130.
28. Champlin RE, Horowitz MM, van Bekkum DW et al. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 1989; 73: 606-613.
29. Hale G, Waldmann H. CAMPATH-1 monoclonal antibodies in bone marrow transplantation. J Hematother 1994; 3: 15-31.
30. McGlave PB. The biology and therapy of chronic myelogenous leukaemia. In: Champlin RE, ed. Bone Marrow Transplantation. Boston: Martin Nijhoff, 1990.
31. Goldman JM. Management of chronic myeloid leukaemia. Blood Rev 1994; 8: 21-29.
32. Allan NC, Richards SM, Shepherd PC. UK Medical Research Council randomised, multicentre trial of interferon-alpha n1 for chronic myeloid leukaemia: improved survival irrespective of cytogenetic response. The UK Medical Research Council's Working Parties for Therapeutic Trials in Adult Leukaemia. Lancet 1995; 345: 1392-1397.
33. The Italian Cooperative Study Group on Chronic Myeloid Leukaemia. Interferon-alpha2s as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia. N Eng J Med 1994; 330: 820-825.
34. Kantarjian HM, O'Brien S, Andorlini P, Talpaz M. Treatment of chronic myelogenous leukemia: current status and investigational options. Blood 1996; 87: 3069-3081.
35. Khouri IF, Kantarjian H, Talpaz M et al. High dose chemotherapy and autologous stem cell transplant for chronic myelogenous leukemia. The MD Anderson experience. Blood 1994; 537a (abstract).
36. Reiffers J, Goldman JM, Meloni G, Cahn JY, Gratwohl A. On behalf of the Chronic Leukaemia Working Party of the EBMT. Autologous stem cell transplantation in chronic myelogenous leukaemia: a retrospective analysis of the European Group for Bone Marrow Transplantation. Bone Marrow Transplant 1994; 14: 407-410.
37. Clift RA, Appelbaum FR, Thomas ED. Treatment of chronic myeloid leukemia by marrow transplantation. Blood 1993; 82: 1954-1956.
38. Anasetti C, Hansen J. Bone marrow transplantation from HLA-partially matched related donors and unrelated volunteer donors. In: Forman ST, Blume KG, Thomas ED, eds. Bone Marrow Transplantation. Boston: Blackwell Scientific Publications, 1994; 665-679.
39. McGlave PB, Beatty P, Ash R, Hows JM. Therapy for chronic myelogenous leukemia with unrelated donor bone marrow transplantation: results in 102 cases [published erratum appears in Blood 1990; 76: 654]. Blood 1990; 75: 1728-1732.
40. Drobyski WR, Ash RC, Casper JT et al. Effect of T-cell depletion as graft-versus-host disease prophylaxis on engraftment. Relapse and disease free survival in unrelated marrow transplantation for chronic myelogenous leukemia. Blood 1994; 83: 1980-1987.
41. Clift RA, Anasetti C, Petersdorf FE, Martin P, Jawsen JA. For the Seattle Marrow Transplant Team. Marrow transplants from unrelated donors for chronic myelogenous leukemia - the Seattle Experience. Exp Hematol 1993; 21: 1111(Abstract).
42. Devergie A, Labopin M, Apperley J et al. For the EMBT Chronic Leukaemia Working Party - Matched unrelated donor (MHD) transplant for chronic myeloid leukaemia (CML) in Europe. Report of 299 cases and analysis of prognosis factors. Exp Hematol 1994; 715(Abstract).
43. Hoyle C, Gray R, Goldman J. Autografting for patients with CML in chronic phase: an update. Hammersmith BMT Team LRF Centre for Adult Leukaemia. Br J Haematol 1994; 86: 76-81.
44. Spencer A, O'Brien SG, Goldman JM. Options for therapy in chronic myeloid leukaemia. Br J Haematol 1995; 91: 2-7.
45. McGlave P. Unrelated donor and autologous marrow transplant therapy of chronic myelogenous leukemia (CML). Leukemia 1993; 7: 1082-1083.
46. Hoelzer D. Treatment of acute lymphoblastic leukemia. Semin Hematol 1994; 31: 1-15.
47. Chessells JM, Bailey C, Richards SM. Intensification of treatment and survival in all children with lymphoblastic leukaemia: results of UK Medical Research Council trial UKALL X. Medical Research Council Working Party on Childhood Leukaemia. Lancet 1995; 345: 143-148.
48. Copelan EA, McGuire EA. The biology and treatment of acute lymphoblastic leukemia in adults. Blood 1995; 85: 1151-1168.
49. Barrett AJ. Bone marrow transplantation for acute lymphoblastic leukaemia. Baillière's Clin Haematol 1994; 7: 377-401.
50. Barrett AJ, Horowitz MM, Ash RC et al. Bone marrow transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia. Blood 1992; 79: 3067.
51. Copelan EA, Kapoor N, Murcek M, Theil K, Tutschka PJ. Marrow transplantation following busulfan and cyclophosphamide as treatment for translocation (4; 11) acute leukaemia. Br J Haematol 1988; 70: 127-128.
52. Gilmore MJ, Hamon MD, Prentice HG et al. Failure of purged autologous bone marrow transplantation in high risk acute lymphoblastic leukaemia in first complete remission. Bone Marrow Transplant 1991; 8: 19-26.
53. Laporte JP, Douay L, Lopez M et al. One hundred twenty-five adult patients with primary acute leukemia autografted with marrow purged by mafosfamide: a 10-year single institution experience. Blood 1994; 84:3810-3818.
54. Jackson GH, Taylor PR, Lennard AL, Proctor SJ. Autologous bone marrow transplantation in acute lymphoblastic leukaemia. Blood Rev 1994; 8: 161-168.
55. Carella AM, Marmont AM. Autologous bone marrow transplantation in acute lymphoblastic leukaemia. Baillière's Clin Haematol 1994; 7: 403-419.
56. Burnett AK, Goldstone A, Stevens RF. The role of BMT in addition to intensive chemotherapy in AML in first CR: the results of the AML X trial. Blood 1994; 84: 252(Abstract).
57. Advisory Committee of the International Bone Marrow Transplant Registry (IBMTR). Report from the International Bone Marrow Transplant Registry. Bone Marrow Transplant 1989; 4: 221-228.
58. Reiffers J, Marit P. HLA-identical sibling bone marrow transplantation for acute nonlymphoblastic leukaemia. In: Atkinson C, ed. Clinical Bone Marrow Transplantation. Cambridge: Cambridge University Press. 1994; 185-191.
59. Zittoun RA, Mandelli F, Willemze R et al. Autologous or allogeneic bone marrow transplantation compared with intensive chemotherapy in acute myelogenous leukemia. European Organization for Research and Treatment of Cancer (EORTC) and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto (GIMEMA) Leukemia Cooperative Groups. N Engl J Med 1995; 332: 217-223.
60. Reiffers J, Marit G, Cony-Makhoul P et al. HLA-identical sibling bone marrow transplantation for acute non-bupivacaine leukaemia. In: Atkinson IC, ed. Clinical Bone Marrow Transplantation. A Reference Textbook. Cambridge, University Press, 1994: 185-190.
61. Ganser A, Hoelzer D. Acute leukaemia. In: Adamson JW, ed. Current Opinion in Hematology: Hematological Malignancies. Philadelphia, PA: Current Science, 1994;1:4:248-255.
62. Schiller G, Feig SA, Territo M et al. Treatment of advanced acute leukaemia with allogeneic bone marrow transplantation from unrelated donors. Br J Haematol 1994; 88: 72-78.
63. Sierra J, Storer B, Hansen J. Unrelated donor marrow transplants for acute leukemia. Blood 1995; 86: 290.
64. Arnold R, de Witte T, Van Beizen A. Matched unrelated donor BMT in myelodysplasia/secondary AML: an EBMT survey. Blood 1995; 86: 95.
65. Chown S, Cornish J, Goulden NE. Matched and mismatched donor bone marrow transplantation for acute myeloid leukemia. Blood 1995; 86: 99 (Abstract).
66. Busca A, Anasetti C, Anderson G et al. Unrelated donor or autologous marrow transplantation for treatment of acute leukemia. Blood 1994; 83: 3077-3084.
67. Gorin WC, Labopin M, Fouillard C. Autologous (ABMT) versus unrelated (MUD) marrow transplantation for acute leukemia. A retrospective survey from the European Cooperative Group for Blood and Marrow Transplantation (EBMT). Blood 1995; 86: 617(Abstract).
68. Young NS. Aplastic anaemia. Lancet 1995; 346: 228-232.
69. Young NS, Barrett AJ. The treatment of severe acquired aplastic anemia. Blood 1995; 85: 3367-3377.
70. Bacigallipo A. Severe aplastic anaemia working party. In EBMT working parties reports, Harrogate, UK, European Group for Bone Marrow Transplantation, 1994: p 49.
71. May WS, Sensenbrenner LL, Burns WH et al. BMT for severe aplastic anemia using cyclosporine. Bone Marrow Transplant 1993; 11: 459-464.
72. Storb R. Bone marrow transplantation for aplastic anemia. Cell Transplant 1994; 2: 365-369.
73. Frickhofen N, Kaltwasser JP, Schrezenmeier H et al. Treatment of aplastic anemia with antilymphocyte globulin and methylprednisolone with or without cyclosporine. The German Aplastic Anemia Study Group. N Engl J Med 1991; 324: 1297-1304.
74. Rosenfeld SJ, Kimball J, Vining D, Young NS. Intensive immunosuppression with antithymocyte globulin and cyclosporine as treatment for severe acquired aplastic anemia. Blood 1995; 85: 3058-3065.
75. Hows JM. Severe aplastic anaemia: the patient without a HLA-identical sibling. Br J Haematol 1991; 77: 1-4.
76. Tichelli A, Gratwohl A, Wursch A, Nissen C, Speck B. Late haematological complications in severe aplastic anaemia. Br J Haematol. 1988; 69: 413-418.
77. Hows J, Szydlo R, Anasetti C, Camitta B, Gajewski J, Gluckman E. Unrelated donor marrow transplants for severe acquired aplastic anemia. Bone Marrow Transplant 1992; 10 Suppl.1: 102-106.
78. Hows JM, Yin JL, Marsh J et al. Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemia. Blood 1986; 68: 1322-1328.
79. Hows JM, Downie TR, Bradley BA et al. Unrelated donor BMT for SAA: European Experience 1989-93. Bone Marrow Transplant 1994; 14 Suppl. 1: 143(Abstract).
80. Kojima S, Inaba J, Kondo M et al. Unrelated donor marrow transplantation for severe acquired aplastic anemia using cyclophosphamide, antithymocyte globulin, and total body irradiation [letter]. Blood 1995; 85: 291-292.
81. Camitta B, Casper J, Pietryga D et al. Unrelated donor marrow transplantation for children with severe aplastic anemia. Blood 1993; 82: 1360.
82. Rabian Herzog C, Lesage S, Gluckman E. Characterization of lymphocyte subpopulations in cord blood. Bone Marrow Transplant 1992; 9 Suppl.1: 64-67.
83. Harris DT, Schumacher MJ, Locascio J et al. Phenotypic and functional immaturity of human umbilical cord blood T lymphocytes. Proc Natl Acad Sci USA 1992; 89: 10006-10010.
84. Emerson SG. Ex vivo expansion of hematopoietic precursors, progenitors, and stem cells: the next generation of cellular therapeutics. Blood 1996; 3082-3088.
85. Nicol AJ, Hows JM, Bradley BA. Cord blood transplantation: a practical option? Br J Haematol 1994; 87: 1-5.